StockNow
Calendar
Log in
Global Markets

Novo (NOVOB DC) targets 2030 pipeline sales of "more than DKK 150bln" and "more than" 5 multi-blockbuster launches, plans to maintain roughly stable adj. operating margin through 2030

StockNow breaking-news AI analysis

Novo targets over DKK 150 billion in 2030 pipeline sales and stable margins, while diversifying into cardiovascular and liver treatments amid unprecedented market competition.

News detail

Competition is at an unprecedented level. CEO: It is time to diversify the company. Novo has gained market share over the past few months. Liver disease and cardiovascular is an obvious place to go. Will launch the next wave of diabetes and obesity innovations long before the loss of exclusivity. Co. will launch the next waves of diabetes and obesity innovations long before the loss of exclusivity.

1 stocks
NVONovo-Nordisk A/S$39.49Current price

What do investors think?

Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactions

StockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.

Today's market highlights

A selection of stories drawing attention in the market.

See more
Geopolitics

Iranian Parliament Speaker Ghalibaf says US President Trump cannot impose his power on Iran, adding that Iran will neither shut down nor surrender

Geopolitics

IRGC says if Iran’s national interests require negotiations alongside war, then it must negotiate; says it will respond to any enemy strike with multiple strikes across different arenas and in various ways, Al Jazeera reports

Geopolitics

Senior Iranian Official says that Tehran welcomes revival of diplomacy if the US takes tangible steps